Please assess the completion status of the following clinical trial:

Trial Title: The Laparotomy Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients \> 18 years old~* Elective open upper abdominal surgery~* Can read and understand Danish~* Informed consent~Exclusion Criteria:~* Known allergy to rocuronium or sugammadex~* Severe renal disease, defined by S-creatinine\> 0.200 mmol/L, GFR \< 30ml/min or hemodialysis~* Neuromuscular disease that may interfere with neuromuscular data~* Abdominal mesh with size larger than 5\*5 cm~* Lactating or pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard neuromuscular blockade (Type: PLACEBO_COMPARATOR): Rocuronium 0.6 mg/kg followed by bolus rocuronium according to standard treatment decided by the attending anesthetist combined with saline infusion (placebo).
- Deep neuromuscular blockade (Type: ACTIVE_COMPARATOR): Rocuronium 0.6 mg/kg followed by rocuronium infusion with target level post tetanic count (PTC) of 0-1 combined with bolus saline (placebo) mimicking standard treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).